Entities / Company
Caribou Biosciences.
company in Berkeley, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 15
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
Gone quiet
No new reports in 90+ days-
Truist Financial upgraded shares of Caribou Biosciences, and MarketBeat provided average rating and price target.Some support1 report
-
Microvast reported $116.49 million in Q1 sales and was added to Russell indexes, while Caribou Biosciences is a clinical-stage biopharma company.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Caribou Biosciences this week
News at the entities that move Caribou Biosciences most-
Royal Bank of Canada OperationalRoyal Bank of Canada and HighTower Advisors LLC increased their holdings in the DoubleLine Income Solutions Fund on October 31, 2026.Moves Caribou Biosciences
-
Leerink partners Mentioned togetherSummit seeks FDA approval for its drug, which was presented at the ASCO meeting. The company is developing ivonescimab with Akeso.Moves Caribou Biosciences
-
Truist Financial TransactionalTruist Financial decreased its price target on Brunswick Corporation, while Morgan Stanley also set a target price for the company.Moves Caribou Biosciences
-
MarketBeat Mentioned togetherClene Inc. is listed on the Nasdaq exchange and MarketBeat provides a consensus rating for the company.Moves Caribou Biosciences
-
Bank of America Mentioned togetherA food drive spanning San Bernardino Valley to Redlands collected donations for Ronald McDonald House in Loma, with participation from Bank of America employees.Moves Caribou Biosciences
Connections
The 6 strongest of 15, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Rachel Haurwitz Structural
Rachel Haurwitz serves as the President and CEO of Caribou Biosciences.
-
Leerink partners Mentioned together
Leerink partners updated Caribou Biosciences ratings, lowering its share performance outlook.
-
Royal Bank of Canada Operational
Royal Bank of Canada downgraded Caribou Biosciences stock, influencing its market valuation.
-
Truist Financial Transactional
Truist Financial issued a share upgrade recommendation for Caribou Biosciences.
-
Bank of America Mentioned together
Bank of America analysts provided price targets and ratings for Caribou Biosciences.
-
MarketBeat Mentioned together
MarketBeat publishes financial ratings and price targets for Caribou Biosciences.